← Back to Clinical Trials
Recruiting NCT07739225

NCT07739225 Patient-Centered Education After Hip Fracture Surgery

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07739225
Status Recruiting
Phase —
Sponsor Assiut University
Condition Hip Fractures
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-09-05
Primary Completion 2027-02-05

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Structured Patient-Centered Educational Program.

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-09-05 with a primary completion date of 2027-02-05.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized controlled trial aims to evaluate the effect of a structured patient-centered educational program on postoperative outcomes among patients undergoing hip fracture surgery. Participants will be randomly assigned to either an intervention group receiving the educational program in addition to routine care or a control group receiving routine care only. The study will assess whether the educational program improves postoperative recovery, functional independence, and pain outcomes following hip fracture surgery.

Eligibility Criteria

Inclusion Criteria: * Patients undergoing hip fracture surgery. * Medically stable and able to participate in the educational program. * Able to understand study instructions and provide written informed consent. Exclusion Criteria: * Cognitive impairment that prevents participation (e.g., dementia). * Severe comorbidities that significantly limit mobility. * Discharged before completion of the educational program.

Contact & Investigator

Central Contact

Aamaa Edrees Fathallah, MSCN

✉ asmaa.edress0986@nursing.aun.edu.eg

📞 +21020910362

Principal Investigator

Samia Youssef Sayed, Prof

STUDY CHAIR

Faculty of Nursing, Assiut University

Frequently Asked Questions

Who can join the NCT07739225 clinical trial?

This trial is open to participants of all sexes, studying Hip Fractures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07739225 currently recruiting?

Yes, NCT07739225 is actively recruiting participants. Contact the research team at asmaa.edress0986@nursing.aun.edu.eg for enrollment information.

Where is the NCT07739225 trial being conducted?

This trial is being conducted at Qina, Egypt.

Who is sponsoring the NCT07739225 clinical trial?

NCT07739225 is sponsored by Assiut University. The principal investigator is Samia Youssef Sayed, Prof at Faculty of Nursing, Assiut University. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology